Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG-Japan vs BCG-Russia in Guinea-Bissau Infants
NCT03400878Phase 4Completed
- Sponsor
- Bandim Health Project
- Start
- Oct 2017
- Primary completion
- Jun 2020
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of BCG Japan in Tuberculosis (TB), Infant mortality (IMR), sponsored by Bandim Health Project. Started Oct 2017; status: completed.
02
Drugs
BCG Japan
03
Conditions
Tuberculosis (TB)Infant mortality (IMR)
Beyond the preview
Go deeper on NCT03400878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03400878.